87.00 +0.25 (0.29%)
Pre-market: 8:11AM EDT
|Bid||86.89 x 800|
|Ask||86.76 x 1000|
|Day's range||86.46 - 86.89|
|52-week range||77.04 - 98.52|
|Beta (5Y monthly)||0.51|
|PE ratio (TTM)||24.64|
|Forward dividend & yield||3.20 (3.69%)|
|Ex-dividend date||04 Mar 2021|
|1y target est||104.67|
According to Wall Street, the following five megacap stocks -- i.e., publicly traded companies with a market cap of at least $200 billion -- offer upside over the next 12 months ranging from 19% to as much as 32%. Is anyone really all that surprised that e-commerce giant Amazon (NASDAQ: AMZN) is on this list?
Novartis (NVS) enters a three-year collaboration with Artios to strengthen its radiogland therapies pipeline.
No surprise then that neighbours Roche and Novartis — both run out of Basel, Switzerland — want to occupy the same ground. For years, differing strategies kept the two pharmaceutical companies apart. Roche was a “pure play” pharma company while Novartis was diversified.